Schedule 13G ownership disclosure
Bright Minds Biosciences Inc
Common Stock, no par value · CUSIP: 10919W405
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Vivo Opportunity Fund Holdings, L.P.
Shares: 454,184.00 · Class: 6.4%
- Vivo Opportunity, LLC
Shares: 454,184.00 · Class: 6.4%
- Vivo Opportunity Cayman Fund, L.P.
Shares: 47,433.00 · Class: 0.7%
- Vivo Opportunity Cayman, LLC
Shares: 47,433.00 · Class: 0.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-111137
- Form type
- SCHEDULE 13G
- Filer
- BRIGHT MINDS BIOSCIENCES INC.
- CIK
- CIK 1827401
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership